Skip to content

Magnetic Resonance Imaging (MRI) of Brain Iron in Neurodegenerative Disease

High Field MRI of Brain Iron in Neurodegenerative Disease

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00249080
Enrollment
182
Registered
2005-11-07
Start date
2005-06-30
Completion date
2007-08-31
Last updated
2009-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Mild Cognitive Impairment, Neurodegenerative Diseases

Keywords

3T MRI, neurodegenerative disease, Alzheimer's disease, spectroscopy, Normal, healthy subject without memory complaint, Not pregnant, MR compatible

Brief summary

Neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, and multiple sclerosis are recognized as a major health concern at the present time. There is information in magnetic resonance imaging (MRI) studies regarding the role of brain iron in normal brain aging that may be enhanced with the use of better scanning equipment and procedures, and by correlating this information with clinical data. This research study aims to develop and evaluate a number of techniques that can potentially improve the effectiveness of three tesla (3T) magnetic resonance imaging of neurodegenerative brain disorders.

Detailed description

Eligibility: A healthy person without memory complaints or someone with neurodegenerative disease. However, the person should not have metal in the body (ie, pacemaker, implants, shrapnel, etc.), should not be pregnant, and should not have claustrophobic anxieties. Study Procedures: During a regular office visit, a neurologist will perform a routine physical and neurological examination, including your medical and family history, to determine your eligibility for this study. You will then be scheduled for a series of neuropsychological tests, which take between 1 to 1.5 hours, and an MRI scan, which takes approximately 1 hour to complete. This is a longitudinal study and you may be asked to repeat these procedures approximately every six months for the duration of this 2 year project.

Interventions

None listed

Sponsors

United States Department of Defense
CollaboratorFED
Albany Medical College
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years or older * Healthy person without memory complaints OR person diagnosed with a neurodegenerative disease (ie, Alzheimer's disease, Parkinson's disease, multiple sclerosis)

Exclusion criteria

* MR contraindication such as metal in body (ie, pacemaker, implant, shrapnel, etc.) * Pregnant * Claustrophobic anxieties

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026